CLRB 241220 2.50C (CLRB241220C2500) Stock Options, News & Quotes

US OptionsDetailed Quotes

CLRB241220C2500

Watchlist

0.05
0.000.00%

15min DelayClose Nov 22 16:00 ET

0.00High0.00Low

Intraday

5D
Daily

News

Express News | Northstar Medical Radioisotopes Executes Supply Agreement With Cellectar Biosciences for Therapeutic Radioisotope Actinium-225 (Ac-225)
ReutersNov 21 08:05 ET
NorthStar Medical Radioisotopes Executes Supply Agreement With Cellectar Biosciences for Therapeutic Radioisotope Actinium-225 (Ac-225)
BusinesswireNov 21 08:00 ET
Maxim Group Maintains Cellectar BioSciences(CLRB.US) With Buy Rating, Maintains Target Price $7
Moomoo NewsNov 20 13:31 ET · Ratings
Positive Buy Rating on Cellectar Biosciences Driven by Promising Iopofosine-131 Results and Strategic Advancements
TipRanksNov 20 13:15 ET · Ratings
Oppenheimer Maintains Cellectar BioSciences(CLRB.US) With Buy Rating, Cuts Target Price to $12
Moomoo NewsNov 19 08:32 ET · Ratings
Oppenheimer Maintains Outperform on Cellectar Biosciences, Lowers Price Target to $12
BenzingaNov 19 08:22 ET · Ratings

Comments

Trytosaveabit

Nov 21 07:08

Update

$Cellectar BioSciences (CLRB.US)$ Reuters· 2 mins ago
Northstar Medical Radioisotopes Executes Supply Agreement With Cellectar Biosciences for Therapeutic Radioisotope Actinium-225 (Ac-225)

Jaguar8

Nov 14 12:32

13G

$Cellectar BioSciences (CLRB.US)$
Cellectar BioSciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Laurence W. Lytton(9.99%)

Trytosaveabit

Nov 14 07:09

Update

$Cellectar BioSciences (CLRB.US)$ Reuters· 2 mins ago
Cellectar Biosciences and Northstar Medical Radioisotopes Announce Partnership for Supply of Actinium-225

Trytosaveabit

Nov 12 07:08

Update

$Cellectar BioSciences (CLRB.US)$ Cellectar Biosciences and SpectronRx Partner to Manufacture Novel Phospholipid Radioconjugate for the Treatment of Cancer
2 MINUTES AGO, 8:05 AM EST
VIA GLOBENEWSWIRE

Jaguar8

Aug 26 05:43

NEWS

$Cellectar BioSciences (CLRB.US)$
Iopofosine I 131 Featured in Two Separate Presentations at 12th International Workshop on Waldenstrom’s Macroglobulinemia
Cellectar Biosciences (NASDAQ: CLRB) announced two presentations on iopofosine I 131 at the 12th International Workshop on Waldenstrom's Macroglobulinemia in Prague.
The first presentation by Dr. Jorge Castillo will showcase a case study of complete central nervous system clearance in a patient with Bing-Neel Syndrome (BNS), a rare compli...